Patent details

EP2364722 Title: Vaccine compositions comprising a saponin adjuvant

Basic Information

Publication number:
EP2364722
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP111688222
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Vaccine compositions comprising a saponin adjuvant
French Title of Invention:
Compositions vaccinales contenant un adjuvant de saponine
German Title of Invention:
Impfstoffzusammensetzungen mit einem Saponin-adjuvans
SPC Number:

Dates

Filing date:
12/12/2006
Grant date:
13/11/2013
EP Publication Date:
13/11/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/09/2011
EP B1 Publication Date:
13/11/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/12/2013
Expiration date:
12/12/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/12/2006
 
 

Name:
GlaxoSmithKline Biologicals S.A.
Address:
rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

Inventor

Name:
Vandepapeliere Pierre
Address:
Belgium (BE)

Priority

1

Priority Number:
0525321
Priority Date:
13/12/2005
Priority Country:
United Kingdom (GB)

2

Priority Number:
0609902
Priority Date:
18/05/2006
Priority Country:
United Kingdom (GB)

3

Priority Number:
0620336
Priority Date:
12/10/2006
Priority Country:
United Kingdom (GB)

4

Priority Number:
0620337
Priority Date:
12/10/2006
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 39/00;
Filing date Document type Number of pages